CUPPINI, LUCIA
CUPPINI, LUCIA
DIPARTIMENTO DI MEDICINA CLINICA E PREVENZIONE (attivo dal 10/07/2006 al 30/09/2012)
Mostra
records
Risultati 1 - 3 di 3 (tempo di esecuzione: 0.007 secondi).
Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8+T cell activation in the presence of adjuvant temozolomide
2018 Pellegatta, S; Eoli, M; Cuccarini, V; Anghileri, E; Pollo, B; Pessina, S; Frigerio, S; Servida, M; Cuppini, L; Antozzi, C; Cuzzubbo, S; Corbetta, C; Paterra, R; Acerbi, F; Ferroli, P; Dimeco, F; Fariselli, L; Parati, E; Bruzzone, M; Finocchiaro, G
Short course radiotherapy concomitant with temozolomide in GBM patients: A phase II study
2017 Fariselli, L; Cuppini, L; Gaviani, P; Marchetti, M; Pinzi, V; Milanesi, I; Simonetti, G; Tramacere, I; Dimeco, F; Salmaggi, A; Silvani, A
Antiangiogenic therapies for malignant gliomas: new markers for targeted treatment
2012 Cuppini, L
| Titolo | Tipologia | Data di pubblicazione | Autori | File |
|---|---|---|---|---|
| Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8+T cell activation in the presence of adjuvant temozolomide | 01 - Articolo su rivista | 2018 | Pellegatta, SerenaPessina, SaraCuppini, LuciaCUZZUBBO, STEFANIACORBETTA, CRISTINA + | |
| Short course radiotherapy concomitant with temozolomide in GBM patients: A phase II study | 01 - Articolo su rivista | 2017 | Cuppini L.Pinzi V.Simonetti G. + | |
| Antiangiogenic therapies for malignant gliomas: new markers for targeted treatment | 07 - Tesi di dottorato Bicocca post 2009 | 2012 | CUPPINI, LUCIA |